Novel Psychoactive Substances

Classification, Pharmacology and Toxicology

Inbunden, Engelska, 2021

1 239 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt över 249 kr.

Beskrivning

Novel Psychoactive Substances: Classification, Pharmacology and Toxicology, Second Edition provides readers with a comprehensive examination on the classification, detection, supply and availability of novel psychoactive substances, otherwise known as "legal highs." The book covers individual classes of novel psychoactive substances that have recently emerged onto the recreational drug scene and provides an overview of the pharmacology of the substance and a discussion of their associated acute and chronic harm and toxicity. This second edition addresses drugs new to the scene, with completely updated and revised chapters.

Written by international experts in the field, this multi-authored book is an essential reference for scientists, clinicians, academics, and regulatory and law enforcement professionals.

Includes chapters written by international experts in the field
Presents a comprehensive overview on the classification, detection, availability and supply of novel psychoactive substances, in addition to the pharmacology and toxicology associated with the substance
Offers a single source for all interested parties working in this area, including scientists, academics, clinicians, law enforcement and regulatory agencies
Provides a full treatment of novel psychoactive substances that have recently emerged onto the recreational drug scene, including amphetamines and the synthetic cannabinoid receptors in 'spice' and 'K2'

Produktinformation

Utgivningsdatum:2021-09-09
Mått:191 x 235 x 32 mm
Vikt:1 290 g
Format:Inbunden
Språk:Engelska
Antal sidor:554
Upplaga:2
Förlag:Elsevier Science
ISBN:9780128187883

Utforska kategorier

Farmakologi inom Medicin

Mer om författaren

Professor Dargan and Dr Wood are both expert advisors on novel psychoactive substances to expert bodies in the UK (Advisory Council on the Misuse of Drugs, ACMD), Europe (European Monitoring Centre for Drugs and Drug Addiction, EMCDDA) and Worldwide (United Nations Office on Drugs and Crime, UNODC). They run a clinical service managing patients with acute drug toxicity, and have a clinical and research interest in novel psychoactive substances. They publish widely in this field and have both been invited to give keynote lectures at International meetings on this topic. David Wood is a Consultant Physician and Clinical Toxicologist at Guy's and St Thomas' NHS Foundation Trust and King's College London, London, UK.

Innehållsförteckning

I. Background1. Legal Classification and International Systems for Monitoring Novel Psychoactive Substances2. Availability and Supply of Novel Psychoactive Substances3. Prevalence of Use of Novel Psychoactive Substances4. Pharmacological Profiling of Novel Psychoactive Substances5. Novel methods of NPS detection and data triangulation6. Social issues in the use of novel psychoactive substances7. General management of the patient with Novel Psychoactive Substance Toxicity8. Addiction and treatment of Novel Psychoactive Substance dependenceII. Analytical Techniques9. Analytical techniques for the detection of novel psychoactive substances and their metabolitesIII. Individual Novel Psychoactive Substances10. Synthetic Amphetamines including novel MDMA analogues11. Pharmacology and Toxicology of N-Benzyl-phenylethylamines (25X-NBOMe) Hallucinogens12. 1-Benzylpiperazine and other Piperazine-based stimulants13. Cathinones14. Arylcyclohexamines15. Synthetic cannabinoids16. Novel opioids17. Novel benzodiazepines18. Tryptamines